| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ACER.13135 |
| P698 | PubMed publication ID | 27375266 |
| P2093 | author name string | Vinay K Gupta | |
| Tomohiro Shirasaka | |||
| Keshav K Gupta | |||
| P2860 | cites work | Epigenetic mechanisms of drug addiction | Q22251252 |
| Alcohol abuse in pregnant women: effects on the fetus and newborn, mode of action and maternal treatment | Q22305612 | ||
| Genetic polymorphisms of alcohol metabolizing enzymes | Q28213908 | ||
| A non-synonymous variant in ADH1B is strongly associated with prenatal alcohol use in a European sample of pregnant women | Q28391686 | ||
| Fetal Alcohol Spectrum Disorder (FASD) Associated Neural Defects: Complex Mechanisms and Potential Therapeutic Targets | Q30436383 | ||
| Prenatal choline supplementation mitigates the adverse effects of prenatal alcohol exposure on development in rats | Q30479199 | ||
| MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis | Q30490362 | ||
| Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans | Q30776528 | ||
| Protective effect of folic acid against oxidative stress produced in 21-day postpartum rats by maternal-ethanol chronic consumption during pregnancy and lactation period | Q32107864 | ||
| Maternal alcohol intake prior to and during pregnancy and risk of adverse birth outcomes: evidence from a British cohort | Q33659639 | ||
| Fetal alcohol spectrum disorders and their transmission through genetic and epigenetic mechanisms | Q33694077 | ||
| Pattern of malformation in offspring of chronic alcoholic mothers | Q34051640 | ||
| Fetal alcohol spectrum disorders: an overview | Q34178996 | ||
| Disposition of ethanol in human maternal venous blood and amniotic fluid | Q34271582 | ||
| Amniotic fluid: not just fetal urine anymore | Q34414762 | ||
| The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes | Q34502898 | ||
| Prenatal alcohol exposure causes long-term serotonin neuron deficit in mice | Q44940015 | ||
| Gene-expression analysis after alcohol exposure in the developing mouse | Q45236912 | ||
| Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with fetal alcohol spectrum disorder | Q45409080 | ||
| Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H19 and IG-DMR in male gametes: implications for fetal alcohol spectrum disorders. | Q45972891 | ||
| Protective effects of the alcohol dehydrogenase-ADH1B allele in children exposed to alcohol during pregnancy | Q46186190 | ||
| Pregnancy outcome following high doses of Vitamin E supplementation | Q46420685 | ||
| Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry | Q46543904 | ||
| Mitochondrially targeted vitamin E and vitamin E mitigate ethanol-mediated effects on cerebellar granule cell antioxidant defense systems | Q46604231 | ||
| Reversal of ethanol toxicity in embryonic neurons with growth factors and estrogen | Q46745607 | ||
| Dihydromyricetin prevents fetal alcohol exposure-induced behavioral and physiological deficits: the roles of GABAA receptors in adolescence. | Q46779268 | ||
| Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression | Q46830977 | ||
| Markers of oxidative stress in placental villi exposed to ethanol | Q46916840 | ||
| Improving executive functioning in children with fetal alcohol spectrum disorders | Q47849354 | ||
| Maternal L-glutamine supplementation prevents prenatal alcohol exposure-induced fetal growth restriction in an ovine model | Q48297141 | ||
| Blood alcohol concentration: a critical factor for producing fetal alcohol effects | Q48326869 | ||
| The investigation of the prenatal and postnatal alcohol exposure-induced neurodegeneration in rat brain: protection by betaine and/or omega-3. | Q49049750 | ||
| Reprogramming of genetic networks during initiation of the Fetal Alcohol Syndrome. | Q50702733 | ||
| Neuroprotective peptides influence cytokine and chemokine alterations in a model of fetal alcohol syndrome. | Q50774435 | ||
| Protective effect of curcumin against chronic alcohol-induced cognitive deficits and neuroinflammation in the adult rat brain. | Q51070217 | ||
| Stage-dependent effects of ethanol on cranial neural crest cell development: partial basis for the phenotypic variations observed in fetal alcohol syndrome. | Q52011908 | ||
| Fetal alcohol spectrum disorder: an overview. | Q52016358 | ||
| Alcohol exposure alters the expression pattern of neural cell adhesion molecules during brain development. | Q52025314 | ||
| Amelioration of ethanol-induced neurotoxicity in the neonatal rat central nervous system by antioxidant therapy. | Q52168554 | ||
| Disposition of ethanol in maternal blood, fetal blood, and amniotic fluid of third-trimester pregnant ewes. | Q54192979 | ||
| Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol | Q34546493 | ||
| Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease | Q34576574 | ||
| Self-regulation therapy increases frontal gray matter in children with fetal alcohol spectrum disorder: evaluation by voxel-based morphometry | Q35145780 | ||
| Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders | Q35188093 | ||
| Rapid induction of apoptosis in gastrulating mouse embryos by ethanol and its prevention by HB-EGF | Q35191564 | ||
| Gene-environment interactions: a review of effects on reproduction and development | Q35989056 | ||
| Human placenta: a human organ for developmental toxicology research and biomonitoring | Q36105644 | ||
| Effects of alcohol, lithium, and homocysteine on nonmuscle myosin-II in the mouse placenta and human trophoblasts | Q36128403 | ||
| Alcohol teratogenesis: mechanisms of damage and strategies for intervention | Q36163342 | ||
| Choline supplementation in children with fetal alcohol spectrum disorders: a randomized, double-blind, placebo-controlled trial. | Q36222985 | ||
| Impairment of social behaviour persists two years after embryonic alcohol exposure in zebrafish: A model of fetal alcohol spectrum disorders | Q36223844 | ||
| Metabolic and genetic factors contributing to alcohol induced effects and fetal alcohol syndrome | Q36565236 | ||
| Stem cell therapy: social recognition recovery in a FASD model | Q36591255 | ||
| Prenatal choline supplementation mitigates behavioral alterations associated with prenatal alcohol exposure in rats | Q36916715 | ||
| Alcohol exposure during development: Impact on the epigenome | Q36988820 | ||
| Maternal alcohol consumption producing fetal alcohol spectrum disorders (FASD): quantity, frequency, and timing of drinking. | Q37311494 | ||
| The power of the zebrafish for disease analysis | Q37417898 | ||
| Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism | Q37579911 | ||
| "Family matters:" fetal alcohol spectrum disorders and the family | Q37592085 | ||
| Cytokines and CNS development | Q37617628 | ||
| Fetal alcohol exposure: consequences, diagnosis, and treatment | Q38074326 | ||
| Review of ethanol dispersion, distribution, and elimination from the fetal compartment | Q38195011 | ||
| The potential of neural stem cell transplantation for the treatment of fetal alcohol spectrum disorder | Q38221442 | ||
| Advances in the development of novel antioxidant therapies as an approach for fetal alcohol syndrome prevention. | Q38240743 | ||
| Dietary selenium plus folic acid as an antioxidant therapy for ethanol-exposed pups | Q39928544 | ||
| Antioxidative treatment diminishes ethanol-induced congenital malformations in the rat. | Q40283626 | ||
| Maternal risk factors in fetal alcohol syndrome: provocative and permissive influences | Q40416349 | ||
| Fetal alcohol syndrome: the vulnerability of the developing brain and possible mechanisms of damage | Q40616375 | ||
| Mitochondrial dna damage and impaired mitochondrial function contribute to apoptosis of insulin-stimulated ethanol-exposed neuronal cells | Q40798520 | ||
| Folates and the fetus | Q41461135 | ||
| Drug disposition in mother and foetus | Q41639067 | ||
| Increased cell death and reduced neural crest cell numbers in ethanol-exposed embryos: partial basis for the fetal alcohol syndrome phenotype | Q41677744 | ||
| A review of alcohol clearance in humans | Q41708910 | ||
| Ascorbic acid inhibits ROS production, NF-kappa B activation and prevents ethanol-induced growth retardation and microencephaly. | Q41920622 | ||
| Human placental biotin transport: normal characteristics and effect of ethanol | Q42287969 | ||
| Ethanol inhibits L-arginine uptake and enhances NO formation in human placenta. | Q42506045 | ||
| Alcohol dehydrogenase 2 genotypes, maternal alcohol use, and infant outcome | Q44235967 | ||
| Zinc supplementation at the time of ethanol exposure ameliorates teratogenicity in mice | Q44288827 | ||
| CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence | Q44460551 | ||
| Fetal alcohol exposure and temporal vulnerability: effects of binge-like alcohol exposure on the developing rat hippocampus | Q44473273 | ||
| Recognition and management of fetal alcohol syndrome | Q44660614 | ||
| Fetal ADH2*3, maternal alcohol consumption, and fetal growth | Q44910288 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1594-1602 | |
| P577 | publication date | 2016-07-04 | |
| P1433 | published in | Alcoholism: Clinical and Experimental Research | Q4713331 |
| P1476 | title | An Update on Fetal Alcohol Syndrome-Pathogenesis, Risks, and Treatment | |
| P478 | volume | 40 |
| Q93145930 | A forebrain undivided: Unleashing model organisms to solve the mysteries of holoprosencephaly |
| Q33892665 | Alcohol and fertility: how much is too much? |
| Q92255883 | Children with Fetal Alcohol Syndrome (FAS): 3D-Analysis of Palatal Depth and 3D-Metric Facial Length |
| Q33602821 | Ethanol itself is a holoprosencephaly-inducing teratogen |
| Q50430676 | FASD: folic acid and formic acid - an unholy alliance in the alcohol abusing mother |
| Q97420453 | Family Environment, Neurodevelopmental Risk, and the Environmental Influences on Child Health Outcomes (ECHO) Initiative: Looking Back and Moving Forward |
| Q28069483 | Fetal Alcohol Spectrum Disorders (FASD): an Approach to Effective Prevention |
| Q96614441 | High concentrations of urinary ethanol metabolites in neonatal intensive care unit infants |
| Q92407242 | Human prenatal exposure to polychlorinated biphenyls (PCBs) and risk behaviors in adolescence |
| Q94468446 | Influences on drinking choices among Indigenous and non-Indigenous pregnant women in Australia: A qualitative study |
| Q61053714 | Insights into retinoic acid deficiency and the induction of craniofacial malformations and microcephaly in fetal alcohol spectrum disorder |
| Q33836748 | Maternal Factors that Induce Epigenetic Changes Contribute to Neurological Disorders in Offspring |
| Q100533628 | Modeling alcohol-induced neurotoxicity using human induced pluripotent stem cell-derived three-dimensional cerebral organoids |
| Q89534720 | Moderate Prenatal Ethanol Exposure Stimulates CXCL12/CXCR4 Chemokine System in Radial Glia Progenitor Cells in Hypothalamic Neuroepithelium and Peptide Neurons in Lateral Hypothalamus of the Embryo and Postnatal Offspring |
| Q98226209 | Murine Models for the Study of Fetal Alcohol Spectrum Disorders: An Overview |
| Q90695441 | Prenatal stress and the developing brain: Risks for neurodevelopmental disorders |
| Q47673700 | Prevalence and Risk of Birth Defects Observed in a Prospective Cohort Study: The Hokkaido Study on Environment and Children's Health. |
| Q48306874 | Preventing Alcohol-Exposed Pregnancies: A Randomized Controlled Trial of a Self-Administered Version of Project CHOICES with College Students and Nonstudents |
| Q91176897 | Retinoic acid signaling reduction recapitulates the effects of alcohol on embryo size |
| Q55162778 | Review and gap analysis: molecular pathways leading to fetal alcohol spectrum disorders |
| Q58802903 | The Effects of Alcohol and Drugs of Abuse on Maternal Nutritional Profile during Pregnancy |
Search more.